Authors: Doo, E Liang, TJ

Citation: E. Doo et Tj. Liang, Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection, GASTROENTY, 120(4), 2001, pp. 1000-1008

Authors: Lu, DTY Khokhar, MF Doo, E Ghany, MG Herion, D Park, Y Kleiner, DE Schmid, P Condreay, LD Gauthier, J Kuhns, MC Liang, TJ Hoofnagle, JH

Citation: Dty. Lu et al., Long-term therapy of chronic hepatitis B with lamivudine, HEPATOLOGY, 32(4), 2000, pp. 828-834

Authors: Schiffmann, R Murray, GJ Treco, D Daniel, P Sellos-Moura, M Myers, M Quirk, JM Zirzow, GC Borowski, M Loveday, K Anderson, T Gillespie, F Oliver, KL Jeffries, NO Doo, E Liang, TJ Kreps, C Gunter, K Frei, K Crutchfield, K Selden, RF Brady, RO

Citation: R. Schiffmann et al., Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease, P NAS US, 97(1), 2000, pp. 365-370

Authors: Doo, E Hoofnagle, JH

Citation: E. Doo et Jh. Hoofnagle, Combination therapy of hepatitis B, GUT, 46(4), 2000, pp. 450-451

Authors: Lau, DTY Doo, E Park, Y Kleiner, DE Schmid, P Kuhns, MC Hoofnagle, JH

Citation: Dty. Lau et al., Lamivudine for chronic delta hepatitis, HEPATOLOGY, 30(2), 1999, pp. 546-549

Authors: Hu, ZY Zhang, ZS Doo, E Coux, O Goldberg, AL Liang, TJ

Citation: Zy. Hu et al., Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex, J VIROLOGY, 73(9), 1999, pp. 7231-7240